Genscript Biotech (1548) Financial Statements

10 Followers

Genscript Biotech Financial Overview

Genscript Biotech's market cap is currently HK$29.23B. The company's EPS TTM is HK$-0.25; its P/E ratio is -1.72; Genscript Biotech is scheduled to report earnings on March 16, 2026, and the estimated EPS forecast is HK$-0.08. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	$ 959.53M	$ 594.49M	$ 839.53M	$ 625.70M	$ 490.10M
Gross Profit	$ 553.20M	$ 272.13M	$ 270.63M	$ 304.08M	$ 282.52M
Operating Income	$ 255.25M	$ 9.28M	$ 26.19M	$ -438.11M	$ -379.29M
EBITDA	$ 317.61M	$ 70.43M	$ -249.42M	$ -389.04M	$ -477.27M
Net Income	$ -532.83M	$ 2.96B	$ -95.48M	$ -226.85M	$ -358.71M
Balance Sheet
Cash & Short-Term Investments	$ 843.01M	$ 621.18M	$ 1.93B	$ 1.46B	$ 1.41B
Total Assets	$ 4.85B	$ 5.28B	$ 3.39B	$ 2.55B	$ 2.23B
Total Debt	$ 523.15M	$ 723.74M	$ 416.99M	$ 349.80M	$ 156.45M
Net Debt	$ 349.55M	$ 591.75M	$ -1.03B	$ -674.20M	$ -1.02B
Total Liabilities	$ 876.30M	$ 954.91M	$ 1.34B	$ 1.18B	$ 846.17M
Stockholders' Equity	$ 3.96B	$ 4.32B	$ 1.39B	$ 1.01B	$ 1.05B
Cash Flow
Free Cash Flow	$ 241.69M	$ -72.27M	$ -444.62M	$ -336.40M	$ -269.83M
Operating Cash Flow	$ 325.52M	$ 75.65M	$ -286.91M	$ -120.29M	$ -136.79M
Investing Cash Flow	$ -171.95M	$ -1.46B	$ -357.73M	$ -443.30M	$ -212.55M
Financing Cash Flow	$ -144.89M	$ 66.52M	$ 1.07B	$ 419.32M	$ 902.14M

Currency in USD

Genscript Biotech Earnings and Revenue History

Income Statement >

Genscript Biotech Debt to Assets

Balance Sheet >

Genscript Biotech Cash Flow

Cash Flow >

Genscript Biotech Forecast EPS vs Actual EPS

Earnings >